Albert David Ltd (ALBERTDAVD)

₹1162.65▲0.96%

Get free price alerts. Set up your Free investment account to get Live Prices. >

Overview

Fundamentals

Q3 '23 Results

Technicals

News and Events

Albert David Ltd share Performance

₹1135.05
₹1180
₹1162.65
2.37%
Low
Day's Volatility:3.87%
High
1.49%
₹554.5
₹1607.9
₹1162.65
52.31%
Low
52 Weeks Volatility:90.60%
High
38.30%

Returns %
1 Month Return	2.33 %
3 Month Return	-20.16 %
1 Year Return	91.45 %

Market Stats
Previous Close	₹1,151.60
Open	₹1,177.90
Volume	8,753.00
Upper Circuit	-
Lower Circuit	-
Market Cap	₹657.56Cr

Company Information

Albert David Limited (ADL), a Calcutta based company, has been providing a range of pharmaceuticalproducts since 1938. With its branches in Ghaziabad and Raisin, the manufacturing portfolio of ADL includes amino acid infusions, disposable syringes and needles, and bulk drugs. With technological collaborations with Morishita Pharmaceuticals Japan and Pharma Plan Germany, ADL has been focusing on expansion and developing innovations such as Siozole Capsules and FerrochelateZCapsules. In 2018-19, ADL's expansion included a Rs 4.68 crore right issue and the launch of INTECARNIMERILTEVICTALROF50. Moving forward, new products such as SIOOXYALAMIN FEZPANSURE are expected to hit the market shortly. ADL is committed to providing quality healthcare solutions at an affordable price.

Share Price: ₹1162.65 per share as on 03 May, 2024 04:01 PM
Market Capitalisation: ₹657.56Cr as of today
Listing date: 14 Jun, 2016
Chairperson Name: A K Kothari

Organisation	Albert David Ltd
Headquarters
Industry	Pharmaceuticals
E-voting on shares	Click here to vote

Key events for Albert David Ltd

Albert David Ltd's ROE Higher Than Industry Average - 12 Mar, 2024
Albert David Limited has a higher Return on Equity (ROE) and net income growth than the industry average. The company retains most of its profits to grow the business, with a low payout ratio of 14%. It also has a history of paying dividends for at least ten years or more.

Fundamentals of Albert David Ltd

Insights on Albert David Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Promoter Holding Up
Promoters have increased holdings from 62.04% to 62.13% in Mar 2024 quarter
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ALBERTDAVD has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.70% to 0.98% in Mar 2024 quarter
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, ALBERTDAVD has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 35.59% to 35.22% in Mar 2024 quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, ALBERTDAVD stock has moved down by -3.4%